Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and Ureter
The incidence of transitional cell carcinoma of the kidney and ureter is low and for that reason limited data exists regarding the appropriate management of regional retroperitoneal lymph nodes. Lymph node metastases have consistently been associated with an adverse prognosis. Howev...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2009-01-01
|
| Series: | Advances in Urology |
| Online Access: | http://dx.doi.org/10.1155/2009/181927 |
| id |
doaj-c3e5afaaabe54abb8b33ad5adf7007e4 |
|---|---|
| record_format |
Article |
| spelling |
doaj-c3e5afaaabe54abb8b33ad5adf7007e42020-11-24T22:53:40ZengHindawi LimitedAdvances in Urology1687-63691687-63772009-01-01200910.1155/2009/181927181927Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and UreterShilajit D. Kundu0Scott E. Eggener1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USASection of Urology, The University of Chicago Medical Center, Chicago, IL 60637, USAThe incidence of transitional cell carcinoma of the kidney and ureter is low and for that reason limited data exists regarding the appropriate management of regional retroperitoneal lymph nodes. Lymph node metastases have consistently been associated with an adverse prognosis. However, five-year cancer-specific survival following nephroureterectomy and lymphadenectomy for patients with lymph node involvement ranges from 0–39%, suggesting a therapeutic benefit. This review covers the primary tumor characteristics associated with lymph node involvement, imaging of the lymph nodes, as well as the rationale, role, patient selection, suggested anatomic templates, and technical considerations for lymphadenectomy.http://dx.doi.org/10.1155/2009/181927 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Shilajit D. Kundu Scott E. Eggener |
| spellingShingle |
Shilajit D. Kundu Scott E. Eggener Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and Ureter Advances in Urology |
| author_facet |
Shilajit D. Kundu Scott E. Eggener |
| author_sort |
Shilajit D. Kundu |
| title |
Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and Ureter |
| title_short |
Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and Ureter |
| title_full |
Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and Ureter |
| title_fullStr |
Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and Ureter |
| title_full_unstemmed |
Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and Ureter |
| title_sort |
retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter |
| publisher |
Hindawi Limited |
| series |
Advances in Urology |
| issn |
1687-6369 1687-6377 |
| publishDate |
2009-01-01 |
| description |
The incidence of transitional cell carcinoma of the kidney and ureter is
low and for that reason limited data exists regarding the appropriate management of
regional retroperitoneal lymph nodes. Lymph node metastases have consistently
been associated with an adverse prognosis. However, five-year cancer-specific survival
following nephroureterectomy and lymphadenectomy for patients with lymph node involvement ranges
from 0–39%, suggesting a therapeutic benefit. This review covers the primary tumor characteristics
associated with lymph node involvement, imaging of the lymph nodes, as well as the rationale,
role, patient selection, suggested anatomic templates, and technical
considerations for lymphadenectomy. |
| url |
http://dx.doi.org/10.1155/2009/181927 |
| work_keys_str_mv |
AT shilajitdkundu retroperitoneallymphnodesintransitionalcellcarcinomaofthekidneyandureter AT scotteeggener retroperitoneallymphnodesintransitionalcellcarcinomaofthekidneyandureter |
| _version_ |
1725662503732510720 |